|
|
Formed in 2001, Early Stage Partners (ESP) invests in information technology, healthcare technologies, advanced manufacturing, and industrial technologies. Managing $100 million in capital, ESP invests primarily in Ohio, Michigan, and the Midwest, though it will consider opportunities in other regions. The firm began raising capital in 2001 and raised $44 million for ESP Fund I, which is now fully deployed. ESP Fund II, with $55 million in commitments, is now actively investing. In addition, a third fund, ESP Fund III, is currently being raised. Early Stage Partners experienced a banner year in 2014, when portfolio companies TOA Technologies, Simbionix and Reverse Medical were sold to strategic investors for a combined value approaching $750 million. TOA Technologies, sold to Oracle, remains the largest ever exit for an Ohio-based software company.
|
